The novelty of our study lies in our approach of monitoring the sequential change of interleukin-6 (IL-6) concentrations, rather than solely relying on threshold values, to predict adverse clinical outcomes such as respiratory failure in patients upon their arrival to the emergency department. The gene discussed is IL6; the disease is respiratory failure.